SARS CoV 2 Infection Found Not to Impact Ovarian Reserve in Women Undergoing Assisted Reproduction

Introduction
The global COVID-19 pandemic has sparked concerns across all fields of medicine, particularly regarding its effects on reproductive health. A recent study sheds light on this issue, revealing that SARS-CoV-2 infection does not affect ovarian reserve in women undergoing assisted reproduction treatments. Visit https://www.obstetricgynecoljournal.com/ for more groundbreaking research in this field.

Understanding the Study Findings
The research, conducted across multiple centers, evaluated whether women who recovered from COVID-19 experienced changes in ovarian reserve by measuring Anti-Müllerian Hormone (AMH) levels. Here are the key highlights:

• Participants: 46 women with previous AMH measurements and confirmed SARS-CoV-2 IgG positivity.
• Grouping: Divided into low responders (AMH < 1 ng/ml) and normal-high responders (AMH ≥ 1 ng/ml).
• Main Result: No significant difference in AMH levels pre- and post COVID-19 infection (1.73 ng/ml vs. 1.61 ng/ml).
• Subgroup Analysis:
  • Normal-high responders: Slight AMH decline (4.6 ng/ml to 3.1 ng/ml).
  • Low responders: Minimal change (0.8 ng/ml to 0.7 ng/ml).

Read the full study at https://doi.org/10.29328/journal.cjog.1001123.

Broader Medical Insights
Interestingly, organizations such as the American Society for Reproductive Medicine (ASRM) have also highlighted that available evidence to date suggests no significant long-term impact of COVID-19 infection or vaccination on fertility outcomes. This aligns well with the findings of this study.

Impact on Assisted Reproductive Treatments
Further assessments showed that key parameters like:

• Gonadotropin dosage
• Days of ovarian stimulation
• Retrieved oocytes
• Fertilization rates

remained consistent before and after COVID-19 infection. This offers much-needed reassurance to patients undergoing fertility treatments.

Further Exploration
You may also be interested in related research from our Fertility and Reproductive Health Section.

A detailed analysis can be found in our main journal article.

Conclusion and Call-to-Action
In conclusion, this robust study provides strong evidence that SARSCoV2 infection does not significantly affect the ovarian reserve in women undergoing assisted reproduction.
Explore more studies at https://www.obstetricgynecoljournal.com/ and join the conversation by sharing your thoughts in the comments below

Disclaimer: This content is generated using AI assistance and should be reviewed for accuracy and compliance before considering this article and its contents as a reference. Any mishaps or grievances raised due to the reusing of this material will not be handled by the author of this article.